Leiomyosarcoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) |
Nima Nasiri (talk | contribs) |
||
Line 29: | Line 29: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Uterine]] Leiomyosarcoma<ref name="SantosCunha2015">{{cite journal|last1=Santos|first1=Pedro|last2=Cunha|first2=Teresa Margarida|title=Uterine sarcomas: clinical presentation and MRI features|journal=Diagnostic and Interventional Radiology|volume=21|issue=1|year=2015|pages=4–9|issn=13053825|doi=10.5152/dir.2014.14053}}</ref><ref name="HataHata1990">{{cite journal|last1=Hata|first1=Kohkichi|last2=Hata|first2=Toshiyuki|last3=Makihara|first3=Ken|last4=Aoki|first4=Showa|last5=Takamiya|first5=Osamu|last6=Kitao|first6=Manabu|last7=Harada|first7=Yuji|last8=Nagaoka|first8=Saburo|title=Sonographic Findings of Uterine Leiomyosarcoma|journal=Gynecologic and Obstetric Investigation|volume=30|issue=4|year=1990|pages=242–245|issn=1423-002X|doi=10.1159/000293278}}</ref><ref name="RhaByun2003">{{cite journal|last1=Rha|first1=Sung Eun|last2=Byun|first2=Jae Young|last3=Jung|first3=Seung Eun|last4=Lee|first4=Soo Lim|last5=Cho|first5=Song Mee|last6=Hwang|first6=Seong Su|last7=Lee|first7=Hae Giu|last8=Namkoong|first8=Sung-Eun|last9=Lee|first9=Jae Mun|title=CT and MRI of Uterine Sarcomas and Their Mimickers|journal=American Journal of Roentgenology|volume=181|issue=5|year=2003|pages=1369–1374|issn=0361-803X|doi=10.2214/ajr.181.5.1811369}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Uterine]] Leiomyosarcoma<ref name="SantosCunha2015">{{cite journal|last1=Santos|first1=Pedro|last2=Cunha|first2=Teresa Margarida|title=Uterine sarcomas: clinical presentation and MRI features|journal=Diagnostic and Interventional Radiology|volume=21|issue=1|year=2015|pages=4–9|issn=13053825|doi=10.5152/dir.2014.14053}}</ref><ref name="HataHata1990">{{cite journal|last1=Hata|first1=Kohkichi|last2=Hata|first2=Toshiyuki|last3=Makihara|first3=Ken|last4=Aoki|first4=Showa|last5=Takamiya|first5=Osamu|last6=Kitao|first6=Manabu|last7=Harada|first7=Yuji|last8=Nagaoka|first8=Saburo|title=Sonographic Findings of Uterine Leiomyosarcoma|journal=Gynecologic and Obstetric Investigation|volume=30|issue=4|year=1990|pages=242–245|issn=1423-002X|doi=10.1159/000293278}}</ref><ref name="RhaByun2003">{{cite journal|last1=Rha|first1=Sung Eun|last2=Byun|first2=Jae Young|last3=Jung|first3=Seung Eun|last4=Lee|first4=Soo Lim|last5=Cho|first5=Song Mee|last6=Hwang|first6=Seong Su|last7=Lee|first7=Hae Giu|last8=Namkoong|first8=Sung-Eun|last9=Lee|first9=Jae Mun|title=CT and MRI of Uterine Sarcomas and Their Mimickers|journal=American Journal of Roentgenology|volume=181|issue=5|year=2003|pages=1369–1374|issn=0361-803X|doi=10.2214/ajr.181.5.1811369}}</ref> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Abnormal vaginal bleeding (Postmenopausal or intermenstrual bleeding or bleeding from uterus or vagina) | * Abnormal [[vaginal bleeding]] ([[Postmenopausal]] or intermenstrual bleeding or bleeding from [[uterus]] or vagina) | ||
* Pressure or pain pelvic or abdomen | * Pressure or pain pelvic or abdomen | ||
* Vaginal | * [[Vaginal discharge]] | ||
* Change in bladder or bowel habits | * Change in bladder or bowel habits | ||
* Fatigue | * [[Fatigue]] | ||
* Fever | * [[Fever]] | ||
* Malaise | * [[Malaise]] | ||
* Weight loss | * [[Weight loss]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Lump protruding from vagina | * Lump protruding from vagina | ||
Line 44: | Line 44: | ||
* Tendenrness on palpating pelvic or Abdomen | * Tendenrness on palpating pelvic or Abdomen | ||
* Lymphadenopathy | * [[Lymphadenopathy]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* ↓ RBC or Hemoglobin may be seen on CBC. | * ↓ [[RBC]] or [[Hemoglobin]] may be seen on CBC. | ||
* In uterine leiomyosarcomas (LMSs) p16 is overexpressed compared with leiomyoma. | * In uterine leiomyosarcomas (LMSs) p16 is overexpressed compared with leiomyoma. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 55: | Line 55: | ||
* Massive uterine enlargement | * Massive uterine enlargement | ||
* Irregular central zones of low attenuation, | * Irregular central zones of low attenuation, | ||
* Extensive necrosis and hemorrhage | * Extensive [[necrosis]] and [[hemorrhage]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Features such as tumor localization, irregular or nodular margins, necrosis, rapid growth, intense contrast enhancement, and restriction at diffusion-weighted imaging can suggest the diagnosis and help differentiate from more common leiomyomas and endometrial carcinoma. | * Features such as tumor localization, irregular or nodular margins, necrosis, rapid growth, intense contrast enhancement, and restriction at diffusion-weighted imaging can suggest the diagnosis and help differentiate from more common leiomyomas and endometrial carcinoma. | ||
Line 83: | Line 83: | ||
* Large,irregular [[Pelvic masses|pelvic mass]] | * Large,irregular [[Pelvic masses|pelvic mass]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* CBC suggestive of anemia | * [[CBC]] suggestive of anemia | ||
* Bcl-2 expression is more frequent and strong marker in leiomyomas compared with leiomyosarcoma. | * [[Bcl-2]] expression is more frequent and strong marker in leiomyomas compared with leiomyosarcoma. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Enlarged uterus with multiple whorled mass lesions, largest of size 8.6×7.1 cm, not extending into the abdomen | * Enlarged [[uterus]] with multiple whorled mass lesions, largest of size 8.6×7.1 cm, not extending into the abdomen | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* An enlarged uterus and a deformed uterine contour are the most common CT findings of leiomyomas | * An enlarged uterus and a deformed uterine contour are the most common CT findings of leiomyomas | ||
Line 105: | Line 105: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemorrhagic]] cellular | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemorrhagic]] cellular [[leiomyoma]]<nowiki/>s (apoplectic [[leiomyoma]])<ref name="pmid4073354">{{cite journal |vauthors=Myles JL, Hart WR |title=Apoplectic leiomyomas of the uterus. A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage |journal=Am. J. Surg. Pathol. |volume=9 |issue=11 |pages=798–805 |date=November 1985 |pmid=4073354 |doi= |url=}}</ref><ref>{{cite journal|doi=10.1097/PAS.0000000000000569.}}</ref> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Abdominal pain | * [[Abdominal pain]] | ||
* [[Vaginal bleeding]] | * [[Vaginal bleeding]] | ||
Line 113: | Line 113: | ||
* [[Urinary retention]] | * [[Urinary retention]] | ||
* [[Constipation]] | * [[Constipation]] | ||
* Infertility | * [[Infertility]] | ||
* [[Bowel obstruction]] | * [[Bowel obstruction]] | ||
* [[Vaginal discharge]] | * [[Vaginal discharge]] | ||
Line 120: | Line 120: | ||
* Large,irregular [[Pelvic masses|pelvic mass]] | * Large,irregular [[Pelvic masses|pelvic mass]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* ↓ RBC or | * ↓ [[RBC]] or [[Hemoglobin]] on [[CBC]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Irregularly enlarged uterus, usually hypoechoic but can be isoechoic and even hyperechoic as well. | * Irregularly enlarged [[uterus]], usually hypoechoic but can be isoechoic and even hyperechoic as well. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Enlarged uterus with irregular border | * Enlarged [[uterus]] with irregular border | ||
| style="background: #F5F5F5; padding: 5px;" | '''T2-weighted MRI''': | | style="background: #F5F5F5; padding: 5px;" | '''T2-weighted MRI''': | ||
* Hypointense masses | * Hypointense masses | ||
Line 133: | Line 133: | ||
* Mitotic figure not exceeding 2/10 HPF, mostly located in the perihemorrhagic areas '''On gross examination:''' | * Mitotic figure not exceeding 2/10 HPF, mostly located in the perihemorrhagic areas '''On gross examination:''' | ||
* Features of multiple hemorrhagic area | * Features of multiple hemorrhagic area | ||
* Necrosis | * [[Necrosis]] | ||
* Cyst formation | * Cyst formation | ||
* Softening, or color different than the usual leiomyoma | * Softening, or color different than the usual leiomyoma | ||
Line 148: | Line 148: | ||
* Lower [[abdominal pain]] with a palpable [[mass]] | * Lower [[abdominal pain]] with a palpable [[mass]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* PECs typically stain for [[Melanocyte|melanocytic]] markers ([[HMB-45]], HMSA-1, Melan A (Mart 1), | * PECs typically stain for [[Melanocyte|melanocytic]] markers ([[HMB-45]], HMSA-1, Melan A (Mart 1), micro-ophthalmia [[transcription factor]] (Mitf), [[myogenic]] markers ([[actin]]), and less commonly [[desmin]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Granulomatous ovoid uterine tumor with a rich vascular network | * [[Granulomatous]] ovoid [[uterine]] [[tumor]] with a rich vascular network | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Mean tumor diameter of 5 cm, well-defined margins, hypodense mass | * Mean tumor diameter of 5 cm, well-defined margins, hypodense mass | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Low and high signal intensity on T1- and T2-weighted MRI | * Low and high signal intensity on T1- and T2-weighted [[MRI]] | ||
* Strong, heterogeneous enhancement | * Strong, heterogeneous enhancement | ||
| style="background: #F5F5F5; padding: 5px;" |'''Microscopic analysis:''' | | style="background: #F5F5F5; padding: 5px;" |'''Microscopic analysis:''' | ||
* Perivascular location | * [[Perivascular cell|Perivascular]] location | ||
* Epithelioid, elongated and spindle shaped, or vacuolated (adipocyte-like). | * Epithelioid, elongated and spindle shaped, or vacuolated ([[adipocyte]]-like). | ||
* Clear to granular, lightly eosinophilic cytoplasm | * Clear to granular, lightly [[eosinophilic]] cytoplasm | ||
* Nuclear atypia | * [[Nuclear]] atypia | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 171: | Line 171: | ||
* Painful, enlarging soft tissue masses | * Painful, enlarging soft tissue masses | ||
* Long bone fractures | * Long [[bone fractures]] | ||
* Arteriovenous shunting and subsequent high-output cardiac failure symptoms such as | * Arteriovenous shunting and subsequent high-output [[cardiac failure]] symptoms such as [[dyspnea]] on exertion. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Peritoneal bleeding in some cases | * [[Peritoneal]] bleeding in some cases | ||
* Painful, enlarging soft tissue masses | * Painful, enlarging soft tissue masses | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Strongly positive for vimentin | * Strongly positive for [[vimentin]] | ||
* Positive for cytokeratin | * Positive for [[cytokeratin]] | ||
* CD31, CD34 | * [[CD31]], [[CD34]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Nonspecific | * Nonspecific | ||
Line 185: | Line 185: | ||
* Bulky or normal size uterus | * Bulky or normal size uterus | ||
* Intratumoral blood flow on Doppler | * Intratumoral blood flow on [[Doppler]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Enhanced huge enhanced round heterogenous solid mass with internal multifocal cysts on CT scan | * Enhanced huge enhanced round heterogenous solid mass with internal multifocal cysts on [[CT scan]] | ||
| style="background: #F5F5F5; padding: 5px;" |'''T2-weighted MRI:''' | | style="background: #F5F5F5; padding: 5px;" |'''T2-weighted MRI:''' | ||
* Focal areas of high signal intensity, known as the “cauliflower-like appearance” on gadolinium-enhanced MRI | * Focal areas of high signal intensity, known as the “cauliflower-like appearance” on gadolinium-enhanced [[MRI]] | ||
| style="background: #F5F5F5; padding: 5px;" |'''Microscopic histology:''' | | style="background: #F5F5F5; padding: 5px;" |'''Microscopic histology:''' | ||
* Nodules, and trabeculae of infiltrative epithelioid to spindled cells | * Nodules, and trabeculae of infiltrative epithelioid to spindled cells | ||
* Eosinophilic cytoplasm. | * Eosinophilic [[cytoplasm]]. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Biopsy and histology | * [[Biopsy]] and histology | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Epithelioid angiosarcoma has a male predilection | * Epithelioid angiosarcoma has a male predilection | ||
* Most often arises in the deep soft tissues (usually intramuscular) of the extremities, but a variety of primary sites, including the thyroid gland can be involved. | * Most often arises in the deep soft tissues (usually intramuscular) of the extremities, but a variety of primary sites, including the thyroid gland can be involved. | ||
* Early nodal and solid organ metastasis, especially to the lungs, bone, soft tissue, and skin. | * Early nodal and solid organ metastasis, especially to the [[lungs]], [[bone]], [[soft tissue]], and [[skin]]. | ||
|} | |} | ||
Revision as of 18:00, 14 March 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
Leiomyosarcoma must be differentiated from other soft tissue tumors, some variants of leimyoma resembles malignant tumor. Other possible differential diagnosis of leimyosarcoma include, epithelioid endometrial stromal sarcoma, epithelioid angiosarcoma.
Differentiating Leiomyosarcoma from other Diseases
The table below summarizes the findings that differentiate Leiomyosarcoma from other conditions that may cause similar signs and symptoms.[1][2][3]
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||
---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||
Lab Findings | Imaging | Histology | |||||||
Ultrasound | CT scan | MRI | |||||||
Uterine Leiomyosarcoma[4][5][6] |
|
|
|
|
|
|
|
Histology and biopsy |
|
Leiomyoma (mitotically active type)[7][8][9][10][11][12] |
|
|
|
T2-weighted MRI:
enhancement
|
|
Biopsy and histology | |||
Hemorrhagic cellular leiomyomas (apoplectic leiomyoma)[13][14] |
|
|
|
|
T2-weighted MRI:
|
On microscopic analysis:
|
Biopsy specimen and histology | ||
PEComa[15][16][17] |
|
|
|
|
|
|
Microscopic analysis:
|
|
|
Epitheloid angiosarcoma[18][19][20] |
|
|
|
|
|
T2-weighted MRI:
|
Microscopic histology:
|
|
|
References
- ↑ Cotton PB, Shorvon PJ (1984) Analysis of endoscopy and radiography in the diagnosis, follow-up and treatment of peptic ulcer disease. Clin Gastroenterol 13 (2):383-403. PMID: 6378443
- ↑ Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R (1993) Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218 (5):583-92. PMID: 8239772
- ↑ Kimura T, Kamiura S, Yamamoto T, Seino-Noda H, Ohira H, Saji F (2004) Abnormal uterine bleeding and prognosis of endometrial cancer. Int J Gynaecol Obstet 85 (2):145-50. DOI:10.1016/j.ijgo.2003.12.001 PMID: 15099776
- ↑ Santos, Pedro; Cunha, Teresa Margarida (2015). "Uterine sarcomas: clinical presentation and MRI features". Diagnostic and Interventional Radiology. 21 (1): 4–9. doi:10.5152/dir.2014.14053. ISSN 1305-3825.
- ↑ Hata, Kohkichi; Hata, Toshiyuki; Makihara, Ken; Aoki, Showa; Takamiya, Osamu; Kitao, Manabu; Harada, Yuji; Nagaoka, Saburo (1990). "Sonographic Findings of Uterine Leiomyosarcoma". Gynecologic and Obstetric Investigation. 30 (4): 242–245. doi:10.1159/000293278. ISSN 1423-002X.
- ↑ Rha, Sung Eun; Byun, Jae Young; Jung, Seung Eun; Lee, Soo Lim; Cho, Song Mee; Hwang, Seong Su; Lee, Hae Giu; Namkoong, Sung-Eun; Lee, Jae Mun (2003). "CT and MRI of Uterine Sarcomas and Their Mimickers". American Journal of Roentgenology. 181 (5): 1369–1374. doi:10.2214/ajr.181.5.1811369. ISSN 0361-803X.
- ↑ Woźniak, Andrzej; Woźniak, Sławomir (2017). "Ultrasonography of uterine leiomyomas". Menopausal Review. 16 (4): 113–117. doi:10.5114/pm.2017.72754. ISSN 1643-8876.
- ↑ Bodner, Klaus; Bodner-Adler, Barbara; Kimberger, Oliver; Czerwenka, Klaus; Mayerhofer, Klaus (2016). "Bcl-2 Receptor Expression in Patients With Uterine Smooth Muscle Tumors: An Immunohistochemical Analysis Comparing Leiomyoma, Uterine Smooth Muscle Tumor of Uncertain Malignant Potential, and Leiomyosarcoma". Journal of the Society for Gynecologic Investigation. 11 (3): 187–191. doi:10.1016/j.jsgi.2003.10.003. ISSN 1071-5576.
- ↑ Adaikkalam J (April 2016). "Lipoleiomyoma of Cervix". J Clin Diagn Res. 10 (4): EJ01–2. doi:10.7860/JCDR/2016/16505.7531. PMID 27190823.
- ↑ Houser, L. Murray; Carrasco, C. H.; Sheehan, C. R. (1979). "Lipomatous tumour of the uterus: radiographic and ultrasonic appearance". The British Journal of Radiology. 52 (624): 992–993. doi:10.1259/0007-1285-52-624-992. ISSN 0007-1285.
- ↑ Keriakos, Remon; Maher, Mark (2013). "Management of Cervical Fibroid during the Reproductive Period". Case Reports in Obstetrics and Gynecology. 2013: 1–3. doi:10.1155/2013/984030. ISSN 2090-6684.
- ↑ Coronado GD, Marshall LM, Schwartz SM (May 2000). "Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study". Obstet Gynecol. 95 (5): 764–9. PMID 10775744.
- ↑ Myles JL, Hart WR (November 1985). "Apoplectic leiomyomas of the uterus. A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage". Am. J. Surg. Pathol. 9 (11): 798–805. PMID 4073354.
- ↑ . doi:10.1097/PAS.0000000000000569. Check
|doi=
value (help). Missing or empty|title=
(help) - ↑ Tan, Y.; Zhang, H.; Xiao, E.-H. (2013). "Perivascular epithelioid cell tumour: Dynamic CT, MRI and clinicopathological characteristics—Analysis of 32 cases and review of the literature". Clinical Radiology. 68 (6): 555–561. doi:10.1016/j.crad.2012.10.021. ISSN 0009-9260.
- ↑ Kang, Jeong Ba; Seo, Jin Won; Park, Young-Han; Jang, Pong Rheem (2014). "Malignant Perivascular Epithelioid Cell Tumor of the Uterus with Lung Metastasis". The Korean Journal of Pathology. 48 (6): 454–457. doi:10.4132/KoreanJPathol.2014.48.6.454. ISSN 1738-1843.
- ↑ "PEComa of the Uterus: A Rare Mesenchymal Tumor Displaying a ≪Snowstorm≫ Pattern at Magnetic Resonance Imaging". Journal of the Belgian Society of Radiology. 100 (1). 2016. doi:10.5334/jbr-btr.926. ISSN 1780-2393.
- ↑ . doi:10.1043/1543-2165-135.2.268. Check
|doi=
value (help). Missing or empty|title=
(help) - ↑ Hwang, Jae Pil; Lim, Sang Moo (2013). "Uterine Epithelioid Angiosarcoma on F-18 FDG PET/CT". Nuclear Medicine and Molecular Imaging. 47 (2): 134–137. doi:10.1007/s13139-013-0191-y. ISSN 1869-3474.
- ↑ Chen, Innie; Firth, Bianca; Hopkins, Laura; Bougie, Olga; Xie, Ri-hua; Singh, Sukhbir (2018). "Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids". JSLS : Journal of the Society of Laparoendoscopic Surgeons. 22 (1): e2017.00066. doi:10.4293/JSLS.2017.00066. ISSN 1086-8089.